- Published at
- by manilatimes.net
positive
positive
News for Syneos Health, Inc. (SYNH)
- Published at
- by gurufocus.com
mixedmixedDiaMedica Therapeutics Appoints Daniel J. O'Connor to the Board of Directors
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on acute ischemic stroke and preeclampsia, today announced the e- Published at
- by investing.com
positivepositiveCorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update By Investing.com
CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update- Published at
- by manilatimes.net
mixedmixed- Published at
- by globenewswire.com
mixedmixedReal World Evidence Solutions Market to hit USD 7 billion by 2032, says Global Market Insights Inc.
Real world evidence solutions industry is projected to witness a CAGR of 15.7% during the period 2024-2032. This growth can be attributed to increasing...- Published at
- by globenewswire.com
neutralneutralScilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase
Successful end of Phase II meeting with FDA leading to an agreed path forward to NDA upon completion of Phase III trials for blockbuster product candidate,...- Published at
- by globenewswire.com
positivepositiveScilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly
Scilex notified NASDAQ on October 28, 2024 that it has set a record date of November 7, 2024 (the “Record Date”) for the dividend of Scilex preferred stock...- Published at
- by globenewswire.com
neutralneutralScilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by w
Scilex Holding Company seeks to maximize the value of its stockholders, including by way of conducting a spinoff or public listing of securities of Scilex...- Published at
- by investing.com
positivepositiveSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously- Published at
- by globenewswire.com
positivepositiveSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously
Semnur is currently in discussions regarding strategic regional and/or worldwide collaborations and potential outright acquisition of SP-102. Any such...- Published at
- by globenewswire.com
positivepositiveClinical Trials Market Size to Worth USD 85.37 Billion by 2033 | Straits Research
The global clinical trials market size was valued at USD 50.02 billion in 2023. It is estimated to reach USD 85.37 billion by 2032, growing at a CAGR of...- Published at
- by investing.com
mixedmixedNew Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the Lipid Lurkers Inside Their Arteries By Investing.com
New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the Lipid Lurkers Inside Their Arteries- Published at
- by investing.com
positivepositiveWhy Etsy (ETSY) Shares Are Plunging Today By Stock Story
Why Etsy (ETSY) Shares Are Plunging Today- Published at
- by globenewswire.com
mixedmixedGlobal Medical Affairs Outsourcing Market Size is Estimated to Reach USD 4.21 billion by 2031, Growing at a CAGR of 11.9%: Straits Research
Due to the rise in clinical trials and the introduction of new medicines, there has been a steady rise in the need for medical affairs service providers...- Published at
- by financialpost.com
mixedmixedNorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers
BELOIT, Wis. — NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and…- Published at
- by investing.com
positivepositiveWhy Is Etsy (ETSY) Stock Rocketing Higher Today By Stock Story
Why Is Etsy (ETSY) Stock Rocketing Higher Today- Published at
- by investing.com
positivepositiveWhy Etsy (ETSY) Stock Is Up Today By Stock Story
Why Etsy (ETSY) Stock Is Up Today- Published at
- by gurufocus.com
positivepositiveGLAZER CAPITAL, LLC Adjusts Position in Tristar Acquisition I Corp
Overview of GLAZER CAPITAL, LLC (Trades, Portfolio)'s Recent Trade GLAZER CAPITAL, LLC (Trades, Portfolio), a prominent investment firm, has recently made a sig- Published at
- by globenewswire.com
positivepositiveReal World Evidence Solutions Market to Reach an Estimate of $5.0 Billion by 2031, With CAGR of 13.7%, Claims Allied Market Research
The global real world evidence solutions market is driven by the rise in the incidence of cancer and chronic illnesses, a significant increase in the...- Published at
- by globenewswire.com
positivepositiveGlobal Contract Research Organization (CRO) Market Size to Reach USD 152.29 Billion in 2030 | Emergen Research
Increasing number of drug development projects across the globe is a key factor driving contract research organization market revenue growth...